Related Experiment Video
Updated: Jun 25, 2026
09:50
Procedure for Human Saphenous Veins Ex Vivo Perfusion and External Reinforcement
Published on: October 1, 2014
Human iliac vein replacement with a tissue-engineered graft.
O E Teebken1, C Puschmann, B Rohde
1Hannover Medical School, Dept. of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover, Germany.
VASA. Zeitschrift Fur Gefasskrankheiten
|February 21, 2009
Summary
Tissue-engineered neo-veins show initial patency for venous reconstruction but can obstruct due to disease progression. This approach may suit specific cases of vein stenosis or obstruction unresponsive to other treatments.
Area of Science:
- Biomaterials Science
- Vascular Surgery
- Regenerative Medicine
Background:
- A modified technique for generating venous conduits using decellularized matrix and autologous cells, previously established in a lamb model, is applied to human tissue.
- The study addresses the challenge of reconstructing large pelvic vessels, specifically the iliac artery and vein, in a patient with a malignant pelvic tumor.
Observation:
- A tissue-engineered neo-vein was created using a decellularized cryopreserved vein allograft, reseeded with autologous endothelial cells from the great saphenous vein.
- The patient underwent reconstruction of the right iliac artery with a cryopreserved arterial allograft and the iliac vein with the neo-vein.
Findings:
- Both the arterial allograft and the neo-vein were initially patent, maintaining patency at 3, 6, 12, and 24 months.
- The tissue-engineered neo-vein became obstructed four months postoperatively due to the progression of the patient's underlying disease.
Implications:
- Tissue-engineered neo-veins represent a potential therapeutic option for selected patients with symptomatic vein stenosis or obstruction.
- This approach may be particularly valuable when interventional methods or standard prosthetic replacements are not curative or suitable.
